PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689,731 | -26.7% | 55,076 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $2,303,985 | +24.2% | 57,499 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $1,854,570 | +3.1% | 45,444 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $1,799,072 | -32.0% | 46,596 | -4.6% | 0.00% | -25.0% |
| Q3 2022 | $2,647,000 | -7.4% | 48,846 | +0.2% | 0.00% | -20.0% |
| Q2 2022 | $2,858,000 | -23.3% | 48,754 | -0.2% | 0.01% | 0.0% |
| Q1 2022 | $3,728,000 | +33.9% | 48,837 | -0.9% | 0.01% | +66.7% |
| Q4 2021 | $2,784,000 | +3.3% | 49,303 | +2.3% | 0.00% | -25.0% |
| Q3 2021 | $2,696,000 | -8.4% | 48,184 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $2,944,000 | -17.8% | 48,511 | -5.0% | 0.00% | -20.0% |
| Q1 2021 | $3,580,000 | +18.7% | 51,072 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $3,015,000 | -0.4% | 50,396 | +0.1% | 0.01% | -16.7% |
| Q3 2020 | $3,027,000 | -64.2% | 50,347 | -68.7% | 0.01% | -62.5% |
| Q2 2020 | $8,451,000 | +70.2% | 161,067 | +8.8% | 0.02% | +45.5% |
| Q1 2020 | $4,964,000 | -29.2% | 148,037 | -4.3% | 0.01% | +10.0% |
| Q4 2019 | $7,007,000 | +22.1% | 154,675 | +2.6% | 0.01% | +11.1% |
| Q3 2019 | $5,738,000 | +2581.3% | 150,724 | +2956.0% | 0.01% | – |
| Q2 2019 | $214,000 | -92.0% | 4,932 | -93.0% | 0.00% | -100.0% |
| Q1 2019 | $2,684,000 | -15.5% | 70,509 | -4.4% | 0.00% | -33.3% |
| Q4 2018 | $3,175,000 | -17.5% | 73,789 | -5.7% | 0.01% | 0.0% |
| Q3 2018 | $3,847,000 | +442.6% | 78,284 | +485.3% | 0.01% | +500.0% |
| Q1 2016 | $709,000 | +146.2% | 13,376 | +257.2% | 0.00% | 0.0% |
| Q4 2015 | $288,000 | +8.7% | 3,745 | 0.0% | 0.00% | – |
| Q2 2015 | $265,000 | -20.4% | 3,745 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $333,000 | -4.9% | 3,745 | -5.1% | 0.00% | 0.0% |
| Q4 2014 | $350,000 | -8.4% | 3,945 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $382,000 | -44.5% | 3,945 | -47.3% | 0.00% | 0.0% |
| Q2 2014 | $688,000 | +187.9% | 7,490 | +119.3% | 0.00% | – |
| Q1 2014 | $239,000 | – | 3,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |